ArticleCancer communications (London, England)2023

Tumor-derived insulin-like growth factor-binding protein-1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors.

Hiroyuki Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.